You are here

Study shows hydroxychloroquine treatments increased coronavirus survival rate by almost three times

Study shows hydroxychloroquine treatments increased coronavirus survival rate by almost three times | 9 June 2021 | A new study shows that the controversial drug hydroxychloroquine touted by former President Donald Trump increased the survival rate of severely ill coronavirus patients. The observational study, published by medRxiv, found that antimalarial drug hydroxychloroquine, along with azithromycin, could increase the coronavirus survival rate by as much as nearly 200% if distributed at higher doses to ventilated patients with a severe version of the illness. "We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients," the study's conclusion states.